Ascendis Pharma A/S
ASND | NASDAQ
$250.89
-$0.38 (-0.15%)
Nov 2, 2026, 11:48 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Net Income | -219.03M | -378.08M | -481.45M | -583.19M | -383.58M | -418.96M |
Depreciation & Amortization | 17M | 17.71M | 18.91M | 17.96M | 15.39M | 9.45M |
Stock-Based Compensation | n/a | 95.51M | 66.66M | 64.18M | 66.83M | 53.17M |
Other Working Capital | 68.84M | 98.13M | 11.25M | 54.33M | 34.34M | 1.03M |
Other Non-Cash Items | 182.44M | 60.98M | 21M | 12.45M | -68.21M | 85.97M |
Deferred Income Tax | 3.21M | 4.84M | 7.3M | 5.38M | -367K | -219K |
Change in Working Capital | 68.16M | -107.16M | -99.79M | -12.47M | -47.72M | -964K |
Operating Cash Flow | 51.77M | -306.2M | -467.36M | -495.7M | -417.65M | -271.55M |
Capital Expenditures | -8.15M | -1.43M | -2.44M | -14.49M | -24.23M | -21.55M |
Cash Acquisitions | n/a | n/a | n/a | n/a | -10.19M | n/a |
Purchase of Investments | n/a | n/a | n/a | -213.84M | -226.04M | -537.75M |
Sales Maturities Of Investments | n/a | 7.35M | n/a | 280.53M | 149.88M | 263.05M |
Other Investing Acitivies | n/a | 950K | 288.92M | 9.54M | -530K | 3.36M |
Investing Cash Flow | -8.15M | 6.88M | 286.47M | 61.73M | -110.58M | -291.2M |
Debt Repayment | -21.09M | 122.79M | 125.82M | 496.93M | -6.43M | -4.77M |
Common Stock Repurchased | -16.71M | n/a | -1.81M | -105.31M | -21.61M | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -10.95M | 11.22M | 10.29M | 5.15M | 11.54M | 26.88M |
Financial Cash Flow | 34.89M | 443.93M | 134.29M | 396.77M | 351.39M | 602.65M |
Net Cash Flow | 122.65M | 167.38M | -52.6M | -1.5M | -138.25M | -13.59M |
Free Cash Flow | 43.62M | -307.62M | -469.8M | -510.19M | -441.88M | -293.1M |
Adj. Free Cash Flow | 43.62M | -403.14M | -536.46M | -574.37M | -508.71M | -346.27M |
Maintenance CapEx | n/a | n/a | n/a | n/a | -19.7M | -21.55M |
Growth CapEx | -8.15M | -1.43M | -2.44M | -14.49M | -4.53M | n/a |
Owner Earnings | 51.77M | -306.2M | -467.36M | -495.7M | -437.35M | -293.1M |
Add to Watchlist
Select watchlists to add or remove ASND